67 類風濕性關節炎病人,若需要長期接受DMARD 藥品治療時,下列何者為最佳之選擇?
(A) gold
(B) penicillamine
(C) azathioprine
(D) methotrexate
答案:登入後查看
統計: A(12), B(20), C(73), D(408), E(0) #412926
統計: A(12), B(20), C(73), D(408), E(0) #412926
詳解 (共 3 筆)
#2881994
常見的疾病修飾抗風濕病藥物(DMARD)有:
hydroxychloroquine (Plaquenil;必賴克瘻)、
sulfasalazine (Salazine;撒樂膜衣錠)、
methotrexate (MTX;治善錠)、
leflunomide (Arheuma;雅努麻)、
D-penicillamine (Metalcaptase;滿克特)、
azathioprine (Asazipam;安思平)、
mycophenolate (Myfortic;睦體康)、
cyclosporine (Sandimmune;新體睦)
17
1
#884794
76 下列何種藥品不屬於DMARD (disease-modifying antirheumatic drugs)?
(A) Hydroxychloroquine
(B)Methotrexate
(C)Sulfasalazine
(D)Phenylbutazone
專技高考◆藥師◆調劑學與臨床藥學- 092-1-藥師-調劑學(包括臨床藥學與治療學)#10633
答案:D
10
1
#4440669
In the long-term application, MTX was the most efficient compound, followed by AZA, whereas CQ had the poorest drug survival.
2
3